A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the effectiveness and safety of Chinese herbal medicines for severe pandemic H1N1 influenza.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study

NCT00936013

Influenza

UNKNOWN PHASE4

Traditional Chinese Medicine for Severe COVID-19

NCT04323332

COVID-19

UNKNOWN PHASE3

Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe Pneumonia

NCT03185923

Community-Acquired Infections

UNKNOWN PHASE3

China Cimicifuga Trial of Climacteric Complaint Control

NCT00622986

Climacteric Symptoms

UNKNOWN PHASE4

Efficacy of Chinese Herbal Medicine to Prevent and Treat COVID-19 Close Contacts

NCT05269511

Healthy Participants

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza A Virus, H1N1 Subtype

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chinese herbal medicines plus western therapy

Group Type EXPERIMENTAL

Chinese herbal medicines plus western therapy

Intervention Type DRUG

injections of Chinese herbal medicines and Chinese herbal medicines decoction\& supportive therapy and antivirus therapy when necessary

western therapy

including supportive therapy and antivirus therapy when necessary

Group Type ACTIVE_COMPARATOR

western therapy

Intervention Type DRUG

supportive therapy and antivirus therapy when necessary

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chinese herbal medicines plus western therapy

injections of Chinese herbal medicines and Chinese herbal medicines decoction\& supportive therapy and antivirus therapy when necessary

Intervention Type DRUG

western therapy

supportive therapy and antivirus therapy when necessary

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of severe pandemic H1N1 influenza patients and pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza
* Rapid Diagnostic Tests:positive
* Age≥6 years
* Influenza symptoms occurred less than 48 hours and body temperature≥37.5℃ for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza